EN DE
STOCK COMPARISON

Caregen Co.Ltd vs ST Pharm Co.Ltd: Fair Value & Quality

Both stocks run through our valuation models. Here is how Caregen Co.Ltd (214370) and ST Pharm Co.Ltd (237690) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees ST Pharm Co.Ltd as the less overvalued of the two: Caregen Co.Ltd trades at KRW 40,200 versus a fair value of KRW 5,953 (-85%), while ST Pharm Co.Ltd trades at KRW 91,300 versus KRW 50,110 (-45%).
Caregen Co.Ltd
214370.KQ · KRW · Health Care
-85%
upside to fair value
overvalued
PriceKRW 40,200
Fair ValueKRW 5,953
Quality72/100
ST Pharm Co.Ltd
237690.KQ · KRW · Health Care
-45%
upside to fair value
overvalued
PriceKRW 91,300
Fair ValueKRW 50,110
Quality44/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Caregen Co.LtdST Pharm Co.Ltd
Valuation
0.03×P/S (TTM)n/a
n/aEV/EBITDA0.6×
−85.2%Fair value upside−45.1%
2.1%Dividend yield0.3%
Profitability
46%Operating margin4%
0.53×EBIT margin trend (5Y)n/a
8%Return on assets1%
Growth
34%Revenue growth (YoY)31%
1.8%Avg. growth/yr (3Y)10.0%
3.8%Avg. growth/yr (5Y)21.7%
−30.0%Value creation/yr+62.9%
Balance & size
n/aInterest coverage (EBIT/interest)13.6×
n/aDebt / equity0.07×
$2BMarket cap$2B
mixedGrowth qualityexpensive

Even match: 4 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Caregen Co.Ltdof which business quality 67 · market factors 21 ST Pharm Co.Ltdof which business quality 46 · market factors 24
ProfitabilityMargins and returns on capital today
51
44
Quality GrowthAre margins and returns improving?
34
83
CashflowEarnings quality: real cash, not paper profit
65
7
Fin. StrengthBalance sheet, leverage, solvency risk
83
73
InvestmentDisciplined investing over empire-building
91
26
Low VolatilityCalm price path (market factor)
50
34
MomentumPrice trend over the last 3–12 months (market factor)
12
21
52W MomentumDistance to the 52-week high (market factor)
4
18
Net IssuanceShare count: buybacks or dilution?
84
52

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyCaregen Co.LtdPrice KRW 40,200ST Pharm Co.LtdPrice KRW 91,300
DCF Models-85%below the priceKRW 5,951-46%below the priceKRW 48,850
Earnings-Based-93%below the priceKRW 2,767-46%below the priceKRW 49,256
Dividend Discount-77%below the priceKRW 9,050n/a
Multiples-82%below the priceKRW 7,134-45%below the priceKRW 50,110
Asset-Based-93%below the priceKRW 2,913-77%below the priceKRW 21,313
Growth DCF-89%below the priceKRW 4,447n/a
Economic Profit-91%below the priceKRW 3,431-72%below the priceKRW 25,505
Growth Earnings-82%below the priceKRW 7,396-20%below the priceKRW 73,028
Minimum-93%below the priceKRW 2,767-77%below the priceKRW 21,313
Maximum-77%below the priceKRW 9,050-20%below the priceKRW 73,028
Median-87%below the priceKRW 5,199-46%below the priceKRW 49,053
Geometric mean-88%below the priceKRW 4,931-55%below the priceKRW 41,052

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Caregen Co.Ltd: 25 of 25 models see the stock below the current price.

ST Pharm Co.Ltd: 14 of 15 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Caregen Co.Ltd
Price KRW 40,200
Fair Value KRW 5,953
Bear KRW 3,905Bull KRW 8,518
ST Pharm Co.Ltd
Price KRW 91,300
Fair Value KRW 50,110
Bear KRW 37,583Bull KRW 62,638

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Caregen Co.Ltd · Health Care

Quality score72 · Top 25%
Fair value upside-85% · bottom 25%

ST Pharm Co.Ltd · Health Care

Quality score44 · below median
Fair value upside-45% · below median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees ST Pharm Co.Ltd as the less overvalued of the two: Caregen Co.Ltd trades at KRW 40,200 versus a fair value of KRW 5,953 (-85%), while ST Pharm Co.Ltd trades at KRW 91,300 versus KRW 50,110 (-45%).

Caregen Co.Ltd has the higher quality score (72/100).

Open ST Pharm Co.Ltd live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.